Wildflower Enters Exclusive Distribution Agreement to Provide CBD Oil to Washington State

VANCOUVER, British Columbia, May 13, 2015: Wildflower Marijuana Inc. (CSE: SUN) (FWB:RSP) (the "Company") has entered into a Letter of Intent to acquire the exclusive rights to market, wholesale and distribute the most advanced cannabidiol vaporizer product on the market for the State of Washington.  The agreement provides for an initial payment of $100,000 which includes exclusivity, $50,000 worth of inventory and a 1.5% override on any online sales or national accounts sold into Washington State. 

The product is a disposable unit filled with e-liquids blended in a pharmaceutical environment under Good Management Practices and ISO certifications. The phytocannabiniod-rich Hempstalk oil, which contains the Cannabidiol (“CBD”) in the device is non-psychoactive and provides a wide-range of benefits, allowing relaxation and added benefits without the ‘high’. 

The e-liquid contains no propylene glycol or polyethylene glycol, which are used in the majority of CBD infused e-liquids on the market, and instead uses only United States Pharmacopeia grade organic vegetable glycerin and other organic, all natural ingredients.  The CBD oils are produced from industrial hemp grown according to the European Union’s eco-farming certification, a standard equally as stringent as the USDA Organic Standards, and are tested at each production batch to ensure they are free of pesticides, heavy metals, and other toxins.  A proprietary extraction process delivers the highest quality extracts that are free of wax or solids and a high concentration of CBDs, ensuring the most effective and efficient delivery of benefits.

CBD demand has increased exponentially, although production has not always kept up with the market changes.  While CBD pills have been available for many years, the vaporization of CBD from hempstalk oil is a relatively new application.  Since this product is legally imported and derived from industrial hemp it can be sold into a wide range of retail outlets, whereas the majority of CBD products in Washington State are derived from cannabis and contain higher levels of THC making it only available in retail marijuana outlets.  The initial targeted retailers will be the over 4600 Natural and Health Food stores, the 800 Vitamin and Supplements stores and the retail cannabis stores.  With integrated technologies such as a fully programmable microprocessor and non-chromium heating elements to control the vaporization temperature, this new method of delivery will be the most advanced on the market.  

President and CEO William MacLean states, “I’m proud to announce the first of our line of CBD products to launch in Washington State.  CBD demand has been increasing in every market and so have the different products available to meet these demands.  With over 6,000 possible retailers initially targeted, Wildflower will have an inherent advantage over competitors who can only market to cannabis retail outlets.”


Wildflower is a cannabis company focused on developing and designing branded products in the marijuana sector.  In this regard, Wildflower works exclusively in Washington State where such activity is permitted and regulated by State law, through entities which hold licenses for such activities.  Further, Wildflower is advancing two applications to grow and distribute medical marijuana under an MMPR license with Health Canada.  Wildflower’s proprietary growing system is designed to maximize crop yields and consistently produce pure clean pharmaceutical grade BC cannabis for patients and cannabinoid research.

On Behalf of the Board of Directors

William MacLean



William MacLean

Director and CEO